AHG:NSD-Akso Health Group ADR (USD)

COMMON STOCK | Medical Distribution |

Last Closing

USD 1.02

Change

+0.01 (+0.99)%

Market Cap

USD 0.24B

Volume

9.79K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-13 )

Largest Industry Peers for Medical Distribution

Symbol Name Price(Change) Market Cap
HSIC Henry Schein Inc

+1.37 (+1.96%)

USD 8.92B
PDCO Patterson Companies Inc

N/A

USD 1.93B
EDAP EDAP TMS SA

-0.09 (-2.78%)

USD 0.12B
YI 111 Inc

+0.09 (+16.07%)

USD 0.05B
COSM Cosmos Health Inc.

+0.14 (+13.43%)

N/A
ZYXI Zynex Inc

+0.22 (+2.76%)

N/A

ETFs Containing AHG

OFOS Exchange Traded Concepts .. 3.45 % 0.00 %

+0.44 (+1.76%)

USD 8.59M

Market Performance

  Market Performance vs. Industry/Classification (Medical Distribution) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 37.84% 100% F 88% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 37.84% 100% F 87% B+
Trailing 12 Months  
Capital Gain -12.82% 71% C- 37% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -12.82% 71% C- 37% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 42.85% 100% F 88% B+
Dividend Return 42.85% 100% F 88% B+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 110.67% 29% F 16% F
Risk Adjusted Return 38.72% 71% C- 70% C-
Market Capitalization 0.24B 60% D- 50% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Underpriced compared to book value

The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector